Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT06102902 |
Title | Testing the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal Cancer |
Recruitment | Recruiting |
Gender | both |
Phase | Phase I |
Variant Requirements | Yes |
Sponsors | National Cancer Institute (NCI) |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
USC / Norris Comprehensive Cancer Center | RECRUITING | Los Angeles | California | 90033 | United States | Details |
Ohio State University Comprehensive Cancer Center | RECRUITING | Columbus | Ohio | 43210 | United States | Details |
University of Oklahoma Health Sciences Center | RECRUITING | Oklahoma City | Oklahoma | 73104 | United States | Details |
M D Anderson Cancer Center | RECRUITING | Houston | Texas | 77030 | United States | Details |
University of Virginia Cancer Center | RECRUITING | Charlottesville | Virginia | 22908 | United States | Details |
Virginia Commonwealth University/Massey Cancer Center | RECRUITING | Richmond | Virginia | 23298 | United States | Details |